Upperton Pharma Solutions is a UK-based leading contract development and manufacturing organisation (CDMO) specialising in formulation development, clinical trial manufacturing and manufacturing services for a wide range of dosage forms, including oral solids, liquids, semi-solids, and inhalation products.

With state-of-the-art facilities and a team of experienced scientists, Upperton offers tailored solutions to accelerate drug development from concept to commercialisation. Upperton are committed to innovation, quality, and share in our customers’ dedication to changing the lives of patients.

Type of Drugs Manufactured:

Small Molecule;Biologics

CDMO Services:

Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

2

High Potent Products capabilities:

OEB 3;OEB 4-5

Facilities Locations:

Europe

Regulatory Approvals for facilities:

GMP

Manufacturing Technologies:

Inhalers;Liquids;Pre-Filled Syringes (PFS);Semi-solids;Solids;Sterile Vials

Current Capacity:

Upperton Ltd continues to elevate the standards of contract manufacturing within the pharmaceutical industry, ensuring a dedicated focus on developing effective solutions for their clients. For more information, visit upperton.com.